Biocure Technology Inc. BICTF

Full chart Compare

Set alert

0.01 USD 0.00 (+0.00%)

At closeNov 10, 2026, 4:00 PM EST

0.07 Day range 0.07

0.01 52-week range 0.07

YTD: 0.00%
1 year: 0.00%

News

6 months ago thenewswire.com Biocure Technology Inc. Announces Adoption of Semi-Annual Reporting Vancouver, B.C. – TheNewswire - May 8, 2026 ‐ Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (the “ Company” or “Biocure”) announces the adoption of semi-annual financial reporting. This news…
2 years ago newsfilecorp.com CSE Bulletin: Consolidation - Biocure Technology Inc. (CURE.X) Toronto, Ontario--(Newsfile Corp. - le 23 octobre/October 2024) - Biocure Technology Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1)…
3 years ago globenewswire.com Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology TÜBINGEN, Germany and MUNICH, Germany, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Atriva Therapeutics GmbH (“Atriva”) is pleased to disclose the signing of an exclusive letter agreement, dated September 14,…
3 years ago newsfilecorp.com Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that it has entered into an exclusive letter agreement…
5 years ago newsfilecorp.com BioCure Technology Inc. Announces New President, Appointment of Capital Markets Advisor and Grant of Stock Options Vancouver, British Columbia--(Newsfile Corp. - July 22, 2021) - BioCure Technology Inc., (CSE: CURE) (OTCQB: BICTF) (CURE or the Company) is pleased to announce that Björn Cochlovius, Ph.D,…
5 years ago newsfilecorp.com BioCure Technology Inc. Announces Closing of Financing Vancouver, British Columbia--(Newsfile Corp. - July 14, 2021) - BioCure Technology Inc. (CSE: CURE) ("BioCure" or the "Company") announces that it has successfully closed a non-brokered private…
5 years ago newsfilecorp.com BiocurePharm, Korea (BPK) Signs MOU With Symbasis GmbH to Develop CAR-T Therapy for Chronic Lymphocyte Leukemia (CLL) Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) (CURE or the Company) BiocurePharm, Korea (BPK), a subsidiary of Biocure…